About the Prohost Portfolio Tables

Today’s Highlights December 5, 2019

Firstly, Forty-Seven and IVERIC bio
We remind that the two condemned stocks Forty-Seven (FTSV) and IVERIC bio (This content is for paid subscribers.

Please click here to subscribe or here to log in.

Today’s Highlights
Amgen (AMGN), AstraZeneca Plc (AZN), Bristol-Myers Squibb (BMY), Forty Seven Inc (FTSV), Galapagos NV (GLPG), Gilead Sciences (GILD), Illumina (ILMN), IVERIC bio (ISEE), Merck (MRK), Novartis (NVS), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX)
December 5, 2019

Tweet Pin It

Other Articles

Precigen Announces Full FDA Approval of PAPZIMEOS, the Only Currently Approved Treatment for Adults with Recurrent Respiratory Papillomatosis

August 15, 2025 0

Approval of BRINSUPRI™ for the Treatment of Non-Cystic Fibrosis Bronchiectasis

August 13, 2025 0

How Alnylam Pharmaceuticals Made Our Day Today and More

July 31, 2025 0

GSK Announces the Linked by Lupus: Optimal Care Initiative to Help Support Individuals with Lupus in the US

July 28, 2025 0

Search ProhostBiotech

Popular Links
Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam Pharmaceuticals (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) CytomX Therapeutics Inc (CTMX) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Neurocrine Biosciences (NBIX) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)

Recent

ProhostBiotech Archive
ProhostBiotech Archive
Sign Up for Weekly Emails
First Name

Last Name

Email address:

Prohost Biotech – Exclusive Biotech Research Copyright © 2025.
© 2014 Prohost Biotech. All rights reserved.
Privacy Policy | Cancellation Policy | Forward Looking Statement

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Exclusive Market Insight

& Scientific analysis

About the Prohost Portfolio Tables